Related Experiment Video
Updated: Jul 13, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Heightened sensitivity to paclitaxel in Class IVa beta-tubulin-transfected cells is lost as expression increases
Hailing Yang1, Fernando Cabral1
1Department of Integrative Biology and Pharmacology, University of Texas Medical School, Houston, Texas 77030.
Abstract:
Stably transfected Chinese hamster ovary cell lines expressing increasing levels of beta4a, a class IV neuronal-specific beta-tubulin, were compared for effects on microtubule organization, assembly, and sensitivity to antimitotic drugs. It was found that beta4a reduced microtubule assembly in proportion to its abundance and thereby caused supersensitivity to microtubule disruptive drugs such as colcemid, vinblastine, and nocodazole. However, the response to paclitaxel was more complex. Low expression of beta4a caused supersensitivity to paclitaxel, whereas higher expression resulted in the loss of supersensitivity. The results suggest that beta4a may possess an enhanced ability to bind paclitaxel that increases sensitivity to the drug and acts substoichiometrically. At high levels of beta4a expression, however, microtubule disruptive effects counteract the assembly promoting pressure exerted by paclitaxel binding, and drug supersensitivity is lost. beta4a-Tubulin differs from the more ubiquitous beta4b isotype at relatively few amino acid residues, yet beta4b expression has little effect on microtubule assembly or drug response. To determine which amino acids mediate the effects of beta4a expression, beta4a and beta4b were altered by site-directed mutagenesis and expressed in Chinese hamster ovary cells. The introduction of N332S or N335S mutations into beta4b-tubulin was sufficient to confer microtubule disruption and increased colcemid sensitivity. On the other hand, mutation of Ala(115) to serine in beta4a-tubulin almost completely reversed heightened sensitivity to paclitaxel, but introduction of an S115A mutation into beta4b had no effect, suggesting that a complex interaction of multiple amino acids are necessary to produce this phenotype.
Insights
Beta4a-tubulin alters microtubule assembly and drug sensitivity. Its expression increases sensitivity to some antimitotic drugs but reduces it to paclitaxel at higher levels, indicating complex interactions.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Microtubules are crucial cytoskeletal components involved in cell division and intracellular transport.
- Beta-tubulin isotypes play distinct roles in microtubule dynamics and drug responses.
- Beta4a-tubulin is a neuronal-specific isotype with largely unknown functions.
Purpose of the Study:
- To investigate the impact of beta4a-tubulin expression on microtubule organization, assembly, and sensitivity to antimitotic drugs.
- To elucidate the specific amino acid residues responsible for beta4a-tubulin's unique effects.
Main Methods:
- Stable transfection of Chinese hamster ovary (CHO) cells with varying levels of beta4a-tubulin.
- Assessment of microtubule assembly dynamics and organization.
- Drug sensitivity assays using colcemid, vinblastine, nocodazole, and paclitaxel.
- Site-directed mutagenesis of beta4a and beta4b-tubulin followed by expression in CHO cells.
Main Results:
- Beta4a-tubulin expression reduced microtubule assembly and increased sensitivity to colcemid, vinblastine, and nocodazole.
- Paclitaxel sensitivity showed a biphasic response: increased at low beta4a expression, decreased at high expression.
- Mutations N332S or N335S in beta4b-tubulin mimicked beta4a's effects on microtubule disruption and colcemid sensitivity.
- Mutation Ala(115) to serine in beta4a-tubulin reversed paclitaxel hypersensitivity, while S115A in beta4b had no effect.
Conclusions:
- Beta4a-tubulin significantly modulates microtubule dynamics and antimitotic drug responses.
- The interaction with paclitaxel is complex, involving substoichiometric binding and counteracting disruptive effects at high expression levels.
- Specific amino acid residues, particularly around position 115 and 332/335, are critical for mediating beta4a-tubulin's distinct functional phenotype.
Related Concept Videos
Drugs that Stabilize Microtubules
Desensitization and Tachyphylaxis
Several...
